APA (7th ed.) Citation

K, B., Z, X., L, T., L, H., TE, P., F, H., . . . E, P. (2026). Targeted Lipid Nanoparticle Delivery of FAP-CAR mRNA Enables Potent In Vivo T-cell Engineering against Pancreatic Tumors. Cancer immunology research, 14(4), 559. https://doi.org/10.1158/2326-6066.CIR-25-0663

Chicago Style (17th ed.) Citation

K, Bajbouj, et al. "Targeted Lipid Nanoparticle Delivery of FAP-CAR MRNA Enables Potent In Vivo T-cell Engineering Against Pancreatic Tumors." Cancer Immunology Research 14, no. 4 (2026): 559. https://doi.org/10.1158/2326-6066.CIR-25-0663.

MLA (9th ed.) Citation

K, Bajbouj, et al. "Targeted Lipid Nanoparticle Delivery of FAP-CAR MRNA Enables Potent In Vivo T-cell Engineering Against Pancreatic Tumors." Cancer Immunology Research, vol. 14, no. 4, 2026, p. 559, https://doi.org/10.1158/2326-6066.CIR-25-0663.